Pages that link to "Q51535629"

The following pages link to Plasma sCD36 is associated with markers of atherosclerosis, insulin resistance and fatty liver in a nondiabetic healthy population (Q51535629):

Displaying 36 items.

• Macrophage-mediated cholesterol handling in atherosclerosis (Q26780405) (← links)
• Circulating CD36 is reduced in HNF1A-MODY carriers (Q28533348) (← links)
• Circulating sCD36 is associated with unhealthy fat distribution and elevated circulating triglycerides in morbidly obese individuals. (Q33554854) (← links)
• Circulating CD36 and oxLDL levels are associated with cardiovascular risk factors in young subjects (Q33576005) (← links)
• CD36, a scavenger receptor implicated in atherosclerosis (Q33844864) (← links)
• CD36 overexpression: a possible etiopathogenic mechanism of atherosclerosis in patients with prediabetes and diabetes (Q33916537) (← links)
• Predicting incident fatty liver using simple cardio-metabolic risk factors at baseline. (Q34329644) (← links)
• CD36 as a therapeutic target for endothelial dysfunction in stroke (Q36139754) (← links)
• Cleavage and reduced CD36 ectodomain density on heart and spleen macrophages in the spontaneously hypertensive rat. (Q36274816) (← links)
• CD36 is a co-receptor for hepatitis C virus E1 protein attachment (Q36602246) (← links)
• The origin of circulating CD36 in type 2 diabetes. (Q36647084) (← links)
• Association between rs1761667 polymorphism of CD36 gene and risk of coronary atherosclerosis in Egyptian population (Q36724023) (← links)
• Soluble cluster of differentiation 36 concentrations are not associated with cardiovascular risk factors in middle-aged subjects (Q36824744) (← links)
• Modes-of-Action Related to Repeated Dose Toxicity: Tissue-Specific Biological Roles of PPAR γ Ligand-Dependent Dysregulation in Nonalcoholic Fatty Liver Disease. (Q38207591) (← links)
• Reduced sCD36 following weight loss corresponds to improved insulin sensitivity, dyslipidemia and liver fat in obese children. (Q39702732) (← links)
• CD36 expression and lipid metabolism following an oral glucose challenge in South Asians (Q40297478) (← links)
• Is plasma soluble CD36 associated with cardiovascular risk factors in early onset coronary artery disease patients? (Q41008794) (← links)
• Arterial Stiffness, Thickness and Association to Suitable Novel Markers of Risk at the Origin of Cardiovascular Disease in Obese Children (Q41454811) (← links)
• Plasma soluble CD36, carotid intima-media thickness and cognitive function in patients with type 2 diabetes (Q41549542) (← links)
• CD36 in chronic kidney disease: novel insights and therapeutic opportunities (Q41935783) (← links)
• Microvesicles Correlated with Components of Metabolic Syndrome in Men with Type 2 Diabetes Mellitus and Lowered Testosterone Levels But Were Unaltered by Testosterone Therapy (Q42133190) (← links)
• A Novel Index Using Soluble CD36 Is Associated with the Prevalence of Type 2 Diabetes Mellitus: Comparison Study with Triglyceride-Glucose Index. (Q42366431) (← links)
• High sCD36 plasma level is associated with steatosis and its severity in patients with genotype 1 chronic hepatitis C. (Q42988922) (← links)
• Macrophage ADAM17 deficiency augments CD36-dependent apoptotic cell uptake and the linked anti-inflammatory phenotype (Q43114569) (← links)
• CD36 expression in peripheral blood mononuclear cells reflects the onset of atherosclerosis. (Q48176124) (← links)
• Lack of pronounced changes in the expression of fatty acid handling proteins in adipose tissue and plasma of morbidly obese humans. (Q48240474) (← links)
• Mechanisms of foam cell formation in atherosclerosis. (Q52759762) (← links)
• Circulating sCD36 levels in patients with non-alcoholic fatty liver disease and controls. (Q53758887) (← links)
• Increased soluble CD36 is linked to advanced steatosis in nonalcoholic fatty liver disease. (Q54739177) (← links)
• SCARF1: a multifaceted, yet largely understudied, scavenger receptor (Q57172358) (← links)
• Circulating Soluble CD36 is Similar in Type 1 and Type 2 Diabetes Mellitus versus Non-Diabetic Subjects. (Q64916657) (← links)
• Myeloid-specific deficiency of pregnane X receptor decreases atherosclerosis in LDL receptor-deficient mice (Q90316142) (← links)
• Contribution of rare coding mutations in CD36 to type 2 diabetes and cardio-metabolic complications (Q91362021) (← links)
• The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis (Q93350798) (← links)
• The Role of CD36 in Type 2 Diabetes Mellitus: β-Cell Dysfunction and Beyond (Q94454413) (← links)
• Understanding lipotoxicity in NAFLD pathogenesis: is CD36 a key driver? (Q99727489) (← links)